Examining Candidemia Mortality Rates Around the World
JUN 09, 2017 | CONTAGION® EDITORIAL STAFF
Snigdha Vallabhaneni, MD, MPH, Medical Epidemiologist, Mycotic Diseases Branch at the Centers for Disease Control and Prevention, discusses candidemia mortality rates in low- and middle-income versus developed countries.
Interview Transcript (slightly modified for readability)
“Mortality with candidemia, from any species, is about 30% to 50%, and it’s higher in low- and middle-income countries, and a little bit on the lower end in the developed world. In the US it’s about 30%, and that’s about the rate of mortality we’ve been seeing with Candida auris.
We still haven’t elucidated risk factors for what, specifically, would cause death. I think the severity of the underlying illness is probably the best predictor. It’s possible that resistant isolates, because it’s harder to treat them, may be a risk factor for death, but we don’t know that yet.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512